Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed)
Department of Health and Human Services
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to support extramural research to investigate and mitigate challenges facing clinical assay development and subsequent analytical validation due to preanalytical variability in tumor tissue biopsies, blood biospecimens utilized as liquid biopsies", or other biospecimens as described in this NOFO. Extramural research funded under this NOFO may include investigations of preanalytical variability associated with the procurement and study of small biopsies (core biopsies, small excision samples), blood utilized for "liquid biopsies", tissue swabs, tissue secretions, pleural and esophageal aspirates, fe
Funding
Award size
Not specified
Type
Cooperative Agreement
Dates
Deadline
Later
Posted
12/13/2024
Closes
2027-09-10
Eligibility
Eligibility
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher educationCounty governmentsFor profit organizations other than small businessesNonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher educationNative American tribal governments (Federally recognized)Small businessesCity or township governmentsSpecial district governmentsIndependent school districtsOthers (see text field entitled "Additional Information on Eligibility" for clarification)Public and State controlled institutions of higher educationState governmentsNative American tribal organizations (other than Federally recognized tribal governments)Private institutions of higher educationPublic housing authorities/Indian housing authorities
Program
Funding area
Education - EDHealth - HL
Opportunity #
PAR-25-325
Source
Status
Open
Market
Government
Level
Federal
Source
Grants.gov